YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.
Saved in:
| Title: | YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells. |
|---|---|
| Authors: | Ma S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA., Sun B; College of Life Sciences, Nankai University, Tianjin, China., Duan S; College of Food Science, Sichuan Agricultural University, Ya'an, China., Han J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA., Barr T; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA., Zhang J; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Los Angeles, CA, USA., Bissonnette MB; Department of Medicine, The University of Chicago, Chicago, IL, USA., Kortylewski M; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA., He C; Departments of Chemistry and Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.; Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, USA., Chen J; Department of Systems Biology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA., Caligiuri MA; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA. mcaligiuri@coh.org.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA. mcaligiuri@coh.org.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA. mcaligiuri@coh.org., Yu J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA. jiayu@coh.org.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA. jiayu@coh.org.; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA. jiayu@coh.org.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA. jiayu@coh.org. |
| Source: | Nature immunology [Nat Immunol] 2023 Feb; Vol. 24 (2), pp. 255-266. Date of Electronic Publication: 2023 Jan 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
